# De Novo Everolimus Versus Tacrolimus in Combination With Mofetil Mycophenolate and Low Dose Corticosteroids to Reduce Tacrolimus Induced Nephrotoxicity in Liver Transplantation: a Prospective, Multicentric, Randomised Study

> **NCT02909335** · PHASE3 · WITHDRAWN · sponsor: **Rennes University Hospital**

## Conditions studied

- Liver Transplantation

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Everolimus
- **DRUG:** Mycophenolate mofetil
- **DRUG:** Prednisolone, Prednisone or Methylprednisolone

## Key facts

- **NCT ID:** NCT02909335
- **Lead sponsor:** Rennes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-11
- **Primary completion:** 2021-11
- **Final completion:** 2021-11
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2022-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02909335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02909335, "De Novo Everolimus Versus Tacrolimus in Combination With Mofetil Mycophenolate and Low Dose Corticosteroids to Reduce Tacrolimus Induced Nephrotoxicity in Liver Transplantation: a Prospective, Multicentric, Randomised Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02909335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*